GlobeMed Pharma Group AG is a Swiss-based platform dedicated to the development, refinement, and scalable production of high-purity phytopharmaceutical ingredients. Our work supports regulated research, formulation development, and ingredient evaluation across Europe, the United States, and international markets.

We operate within quality frameworks aligned to Swiss-GMP, EU-GMP, and global pharmacopoeial standards. Our processes emphasize analytical consistency, documentation integrity, and traceable quality controls supported by accredited third-party laboratories. Every stage is designed to ensure reproducibility, transparency, and alignment with international regulatory expectations.

Our platform integrates genetic, biochemical, expression, and purification sciences to support high-precision ingredient development. These capabilities allow for advanced characterisation, process optimization, and scalable production models suitable for controlled and regulated environments. We focus on developing specialized phytochemical profiles and high-quality raw-material characteristics that meet stringent pharmaceutical requirements.

Across early research, analytical development, stability guidance, and scale-up, we prioritize data clarity, controlled-process validation, and comprehensive quality documentation. Our vertically integrated structure enables partners to work within a unified scientific and compliance framework that supports innovation while maintaining regulatory readiness.

We collaborate exclusively with regulated pharmaceutical companies, research institutions, and organizations operating within formal quality and compliance systems. Our goal is to provide a reliable, science-driven platform that advances modern phytopharmaceutical development while upholding strict Swiss and international standards.

Globemed Pharma Group AG

Org chart

Teams

Offices

Globemed Pharma Group AG

Org chart

Teams

Offices

Related companies